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Introduction and Objective

The Liver Imaging Reporting and Data System (LIRADS)
was created to standardize the reporting and data collection
of MR imaging for hepatocellular carcinoma (HCC) in high
risk patients. The major categories for LIRADS have the
following descriptors:
LI-RADS 1 = Definitely benign
LI-RADS 2 = Probably benign
LI-RADS 3 = Intermediate probability for HCC
LI-RADS 4 = Probably HCC
LI-RADS 5 = Definitely HCC
LI-RADS 5V = Definitely HCC with tumor in vein
LI-RADS M = Probable malignancy, not specific for HCC
LI-RADS T = Treated Observation
However, there is a paucity of quantitative evidence for the
progression of LIRADS 2, 3 and 4, (hereafter defined as
intermediate LIRADS categories) to LIRADS 5. Our
objective was to investigate the conversion of intermediate
LIRADS categories to definite hepatocellular carcinoma
(LIRADS 5) to help inform management decisions
regarding treatment and better stratify imaging follow up for
high-risk patients with intermediate LIRADS categories.

Methods
1)

2)

A retrospective imaging database search at a single institution from 2005 to 2015,
yielded 269 Korean immigrant patients with Chronic Hepatitis B Virus (HBV) who
underwent annual MR screening.
For these patients, the initial and most recent LIRADS scores were obtained from
electronic medical records. Analysis was performed using IBM SPSS 21.0.
1.
2.

Results
1)

125 patients (46 %) had at least one
focal hepatic lesion.
50/50
2) A total of 60 patients had at least
one
follow up study for evaluation.
3) 48 (80%) had MR evidence of
cirrhosis.
4) 38 (63%) had or developed LIRADS 5
lesions or biopsy-proven HCC.
- No LIRADS 1 lesions progressed to
LIRADS 5 or biopsy proven HCC.
- 14.3 % (1/7), 36.3 % (4/11) and 100 %
(7/7) of LIRADS 2, 3 and 4 lesions
respectively, progressed to LIRADS 5
or biopsy proven HCC.
4) The mean duration to LIRADS 5 50/50
were 9
years, 2.7 years (10 months - 4.3 years), and
9 months (2 months - 3 years) respectively
for LIRADS 2, 3 and 4 lesions.

Conclusions
These results are concordant with the presently used descriptors of intermediate LIRADS
categories. The differing conversion rates to definite HCC of each LIRADS category
suggests shorter interval imaging follow up for higher LIRADS categories. LIRADS 4
lesions may be managed similarly to LIRADS 5 lesions, obviating the need for biopsy, and
directly pursuing treatment. A larger sample size is needed to corroborate these findings.
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